Skip to main content
. Author manuscript; available in PMC: 2014 May 20.
Published in final edited form as: Clin Cancer Res. 2011 Jul 7;17(16):5367–5378. doi: 10.1158/1078-0432.CCR-10-3176

Figure 2. Expression and activity of Src kinase in mucinous ovarian carcinomas.

Figure 2

(A) Src pathway specific analysis with gene network ontology is shown. Expressions of mucinous ovarian carcinoma cell lines were compared to ovarian serous carcinoma cell lines. (B) Western blot analysis for phospho-src (p-src) and src kinase in 14 cell lines is shown. Cells were incubated in serum containing media and collected in 70–80% confluence. (C) Immunohistochemistry staining for src kinase and phospho-src for human mucinous ovarian carcinomas are shown (magnification ×200). (D) Cell viability assay for 3 cell lines and 6 chemotherapeutic agents is shown.